2016
DOI: 10.1016/j.tox.2016.05.024
|View full text |Cite
|
Sign up to set email alerts
|

Nonylphenol effects on human prostate non tumorigenic cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
30
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2
2

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 74 publications
0
30
1
Order By: Relevance
“…Indeed, perturbation of cell cycle and enhanced proliferation concomitant with genetic instability are considered as a risk factor for the development of cancer. Nonylphenol-dependent stimulation of clastogenic and mutagenic mechanisms as well as enhanced cell cycle and proliferation has been reported many times in different in vitro and in vivo models ( 31 , 39 41 ).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, perturbation of cell cycle and enhanced proliferation concomitant with genetic instability are considered as a risk factor for the development of cancer. Nonylphenol-dependent stimulation of clastogenic and mutagenic mechanisms as well as enhanced cell cycle and proliferation has been reported many times in different in vitro and in vivo models ( 31 , 39 41 ).…”
Section: Discussionmentioning
confidence: 99%
“…Hormone-driven-characterized stages such as utero, infancy, childhood, puberty, and menopause are the most sensitive exposure periods [ 10 , 11 , 12 , 13 , 14 ]. Regarding carcinogenesis, recent studies have showed the relation of exposure to NP to the risk of breast cancer in women [ 15 ] and prostate cancer in men [ 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…The endocrine disruptive properties of APs are of particular concern. Several studies have demonstrated the estrogenic activity of APs by mimicking 17b-estradiol in PNT1A human prostate cells, inducing cell proliferation and binding to progesterone receptor in human estrogen-sensitive MCF7 cells, triggering mitotic activity in the endometrium of rats, and inducing P450 aromatase activity in JEG-3 human placental cells (Forte et al, 2016;P erez-Albaladejo et al, 2017;Soto et al, 1991). The human placental choriocarcinoma JEG-3 cell line expresses high levels of P450 aromatase, a key enzyme in steroidogenesis.…”
mentioning
confidence: 99%